Enrich Therapeutics

As Co-founder and Chief Executive Officer, Dong leads Enrich Biosystems in its mission to develop a highly integrated high-throughput cell imaging/analysis/capture platform and unleash its microfluidics-free technology to accelerate cell-based biology and therapy discovery, precision medicine, and many other critical life science applications. Kevin has over 20 years of successful commercial experience in market-leading and start-up life science research companies. Prior to joining Enrich Biosystems Inc., Kevin was a leading contributor in the commercial adoption of innovative solutions from Leica Microsystems, Perkin Elmer, ForteBio and others. Cyndi is active as a mentor and provides consultant expertise for a variety of organizations, including ABCT, eLabNYC, Springboard Enterprises and Endless Frontier Labs. McLeod co-founded AxioMx, Inc., serving as President and CEO. TROVO is a novel microgel lithography cell capture and discovery platform. TROVO’s microwell mode provides the flexibility to create up to 24,000 custom microwells of any size and shape on a standard 6-well culture plate. Enrich Biosystems Joins Cell Manufacturing Research Initiative to Further Advance Cell Therapy Discovery.